High-Resolution Exploration of ECM-based Vascularized Tissue-Flaps

Join Dr. Idan Redenski for a discussion on the use of high-resolution microCT to assess vascular development and bone turnover when fabricating composite tissue flaps.

Functional regeneration of complex large-scaled defects requires both soft and hard tissue grafts. Autologous tissue-harvest, considered as the standard of care in clinical settings, possess major procedural drawbacks.

In this webinar, Dr. Redenski describes how they employ a tissue engineering approach based on biological tissue constructs in order to fabricate composite tissue flaps by combining synthetic soft-tissue matrices and biological bone matrix. He goes on to share how high-resolution microCT was used, both ex vivo and in vivo, to evaluate vascular development and bone turnover.

Key Topics Include:

Contrast-agent perfusion
In vivo microCT scans
High resolution vascular imaging

Who Should Attend?

This webinar will be of particular interest to preclinical researchers who specialize in cardiovascular-, neurovascular-, and oncology, as well as contract research organizations.

Presenters

Idan Redenski, DMD, PhD

Researcher
Galilee Medical Centre

Dr. Idan Redenski holds a dual degree in DMD-MSc specializing in microbial biofilms and laser therapy from the Hebrew University. Following that, in 2016, Idan began his PhD work in biomedical engineering at the Technion Institute of Technology, under the supervision of Professor Shulamit Levenberg. His research focused on stem-cell based vascularization and ECM based vascularized composite tissue fabrication. Most recently, in 2021, Dr. Redenski began a research-oriented residency in oral and maxillofacial surgery at the Galilee Medical Centre, with a focus on regenerative medicine and 3D-bioprinting.

Watch Webinar

Webinar Host

Bruker Corporation

Bruker offers preclinical imaging solutions for a broad spectrum of application fields, such as cancer research, neuroimaging and cardiac disease.

VIEW PROFILE

Additional Content From Bruker Corporation

Unlocking Your Clinical Understanding of Post-Acute COVID Syndrome (PACS), Patient Recovery, and Risk of Subsequent Disease

Watch this webinar to learn about the metabolic changes during COVID-19 disease, how these can be accurately tracked and how NMR can improve the clinical understanding of Long-COVID.

Cardiac PET/MR Imaging in Small Rodents

Experts provide a comprehensive overview of approaches to address cardiac and respiratory gating in PET and MRI in rodent models.

SmartDriveNMR – The Next Generation of Automation

Bruker experts provide an overview of SmartDrive with a particular focus on the exciting new features. They offer practical examples and demonstrate the newest features and functions live!

Related Content

Photoacoustic Imaging in Angiotensin II Induced Cardiac Hypertrophy Mice

Hear Dr. Emily Lupton on her lab's investigation whether photoacoustic imaging (PAI) could provide novel imaging in the heart after angiotensin-II induced hypertrophy with and without treatment with losartan.

The Translational Utility of Ultrasound and Photoacoustics in Head and Neck Oncology

Dr. Mukund Seshadri presents his interdisciplinary research on developing and evaluating ultrasound and photoacoustic imaging for oral oncology applications, with a focus on the prognostic utility of these methods in assessing treatment responses in head and neck cancer patients.

Functional Ultrasound Neuroimaging: Principles, Applications, & Perspectives

Dr. Mickael Tanter presents his work on functional ultrasound neuroimaging, including an overview and translation to clinical applications.